Therapy: Monitoring risk of anterior uveitis in AS

Nature Reviews Rheumatology 13, 258 (2017). doi:10.1038/nrrheum.2017.48 Author: Jessica McHugh In a study of patients with ankylosing spondylitis (AS), the rate of anterior uveitis was reduced upon treatment with adalimumab (n = 406) or infliximab (n = 605) compared with pretreatment rates. The opposite was seen in patients receiving etanercept treatment

http://feeds.nature.com/~r/nrrheum/rss/current/~3/Pna2exPaVn0/nrrheum.2017.48

Source: Nature Reviews Rheumatology - March 23, 2017 Category: Rheumatology Authors: Jessica McHugh Tags: Research Highlight Source Type: research